Valproate semisodium

Valproate semisodium (INN) or divalproex sodium (USAN) consists of a compound of sodium valproate and valproic acid in a 1:1 molar relationship in an enteric coated form. It is used in the UK and US for the treatment of the manic episodes of bipolar disorder, and increasingly taken long-term for prevention of both manic and depressive phases of bipolar disorder, especially the rapid-cycling variant. It is also used in the US for the treatment of epilepsy, chronic pain associated with neuropathy, and migraine headaches. Its chemical name is sodium hydrogen bis(2-propylpentanoate). The extended release formulation allows for a single daily dose.

In the UK semisodium valproate has been sold for a few years as the proprietary drug Depakote and marketed for psychiatric conditions only. It is about five times the price of sodium valproate, which has been marketed for around 30 years as Epilim by the same company for epilepsy and is also available from other manufacturers as a generic product.

Branded Formulations

  • Brazil - Depakote® by Abbott Laboratories
  • Canada - Epival® by Abbott Laboratories.
  • United Kingdom - Depakote® by Sanofi-Aventis
  • United States - Depakote® and Depakote ER® (Extended Release) by Abbott Laboratories

    • © Medic8 ® All Rights Reserved.